A New CRISPR-Engineered Cancer Model to Test Therapeutics – Technology Networks
Technology Networks |
A New CRISPR-Engineered Cancer Model to Test Therapeutics
Technology Networks Using multiplex CRISPR-Cas9 editing of human hematopoietic, or blood-forming, stem cells followed by transplantation in mice, the team designed customized mouse models for the progression of leukemia. In a number of different experiments, the animal … |
